Ian Wyatt
Top Stock Insights
Chuck Carlson
The DRIP Investor
Jim Stack
InvesTech Market Analyst
Mark Skousen
Hedge Fund Trader

Digital duo: Electronic medical records


Bookmark and Share
by Andy Obermueller, editor Game-Changing Stocks

Andy ObermuellerThe reasoning behind electronic medical records is simple: efficiency. Digital records will help  end medical errors, stop unnecessary tests and eliminate the danger of improper drug interaction -- all while streamlining workloads, decreasing paperwork and lowering costs.

Computerized records can revolutionize the industry, just as they did for banking and retail. And athenahealth (ATHN) and Allscripts (MDRX) are my favorite software plays on this market.

When the American Recovery and Reinvestment Act -- known as the Stimulus Act -- was signed in 2009, it incorporated the HITECH Act and federal "meaningful use" incentive program for digital medical records.

HITECH provides some $35 billion in subsidies to physicians and hospitals that prove they have adopted and are using EHR technology. But most of these health care providers have yet to begin the process.

So how much will our nation's health care system be spending to convert to a completely digitized system?

At an average cost to hospitals of $100,000 per licensed bed for electronic health records (EHR) software, the total price tag for the conversion to these systems has been estimated at nearly $100 billion.

Estimates for doctors' offices vary, but a sampling of the forecasts I found started at $25,000 per physician. There are nearly 700,000 doctors in the United States, which conceivably adds another $17.5 billion.

This won't be a one-time deal, either. The digitization of our medical records will require future software updates and upgrades. As our health care system finally enters the age of the Internet, there will continue to be opportunities for EHR companies to innovate the space.

Right now, two of my favorite software companies are athenahealth and Allscripts -- both of which should see increased revenue as more hospitals make the switch to their EHR software.

Athenahealth is already showing signs of increased revenue from the spending. In 2011, it brought in $324.5 million, up from $245.5 million in 2010 -- a 32% gain. The company serves nearly 33,000 medical providers, including more than 23,200 physicians.

My other favorite, Allscripts, at last count, sells its products to over 180,000 physicians, 1,500 hospitals and 10,000 post-acute organizations, which help patients transition from long-term hospital care back to the community.

Its marketing is methodical: One practice at a time, one system at a time, one region at a time. Once it gains a customer, it seeks to sell to everyone that provider works with, then, every provider that all of those caregivers work with, until the entire region is using the same seamless Allscripts system.

So far the company's method seems to be working... Allscripts was able to double its revenue to $1.4 billion in 2011, compared to a year earlier.

Of course, with investing, nothing is 100% certain. These are both smaller companies, so you can expect above average volatility if the market suffers a set-back.

But one thing is for certain... the new medical EHR software is going to be big. And with 80% of U.S. hospitals still yet to implement the program, both Allscripts and athenahealth could be clear beneficiaries.

Learn more about this financial newsletter at Andy Obermuellers's Game-Changing Stocks.

Related articles:

Advertisement
Banner
News Flash

Split buys? HOMB and Noble Energy
by Neil Macneale, editor 2-for-1 Stock Split Newsletter

Each month, we add one stock to our model portfolio based upon those companies that have announced 2-for-1 stock splits; after a meager number of splits over the past year, we have a nice collection of six splits elect from this month.


Read more...

 

WisdomTree targets global bonds
by Mark Salzinger, editor The Investor's ETF Report

While most investors diversify the equity portions of their portfolio with allocations to foreign stocks, few diversify their bond holdings internationally. WisdomTree recently introduced the first ETF to invest in a truly global portfolio of corporate bonds.


Read more...


   

Express Scripts: Obamacare buy
by J. Royden Ward, editor Cabot Benjamin Graham Value Investor

I am attracted to healthcare stocks because the confusion surrounding “ObamaCare” has held healthcare stock prices back. I think Express Scripts (ESRX) is very likely to shine in 2013.


Read more...

 

Hodges: High conviction funds
by Walter Frank, editor MoneyLetter

Over the last two months, Hodges Fund (HDPMX) has made a strong run to the top echelons of our domestic stock fund rankings. And one of its siblings, Hodges Small Cap (HDPSX) has been within the top decline of the small blend category from 2009 through last year, and is in the top 20% this year.


Read more...

 

United Natural: A play on Whole Foods
by Mark Skousen, editor Hedge Fund Trader Alert

We’ve recommended Whole Foods Market (WFM) from time to time, and the stock has moved up sharply in the past three years, but I’d like to suggest an alternative -- one of Whole Foods’ primary suppliers, United Natural Foods (UNFI).


Read more...

 

Timing expert eyes India
by Sy Harding, editor Street Smart Report

The money flow and momentum reversals in India's Bombay Index have now been enough to trigger buy signals on intermediate-term indicators. With this new buy signal, we have added a position in the iShares India 50 ETF (INDY) to our portfolio.


Read more...

 

Value investor goes with Guess
by Charles Mizrahi, editor Hidden Values Alert

Guess?, Inc. (GES) is a holding in our special situation portfolio; its strong product quality has created brand name recognition and a loyal consumer following.


Read more...

 

MGAM: Bingo, lotteries, casinos
by Jim Oberweis, Jr., editor The Oberweis Report

Multimedia Games Holding Company (MGAM) makes innovative gaming systems for Native American and commercial casino operators in North America, lottery operators, and charity and commercial bingo operators.


Read more...

 

Fidelity expert: Bowers' bond bets
by Jack Bowers, editor Fidelity Monitor & Insight

If you’ve been worried that the bond market might take a big hit, you can relax. Indeed, while bond funds may lag stock funds over the next 5-10 years, they still have a decent shot at keeping up with inflation, and they remain an excellent way to cut risk in a blended portfolio.


Read more...

 

Tesla: 'Out of the ball park'
by Timothy Lutts. editor Cabot Stock of the Month

Tesla (TSLA), our previously featured Stock of the Month and our top stock pick for 2013, knocked the ball out of the park in its latest quarter. The company exceeded analysts' expectations on all counts: cars sold, revenues, earnings, gross margins and more.


Read more...

 



Banner



Close
Select Offer: Schwab Options Market Commentary